Stephen Cornelissen/LinkedIn
Feb 4, 2026, 08:05
Stephen Cornelissen Honors the Life-Saving Impact of Blood Donation on World Cancer Day
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”On World Cancer Day, I’m reminded that behind every diagnosis is a person and a story shaped by resilience, fear, hope, and the people who stand beside them.
Blood cancer patients are the largest users of donated blood in Australia.
More than a third of all whole blood donations support cancer treatment, helping patients stay strong enough to undergo chemotherapy and other intensive therapies.
These donations don’t treat the cancer itself, but they make treatment possible.
It highlights the vital role Australian Red Cross Lifeblood donors play in supporting patients through treatment.”
Stay updated with Hemostasis Today.
-
May 6, 2026, 14:20Emmanuel J. Favaloro: New Issue Released on Advancing Global Haemostasis Testing in Thrombosis and Hemostasis
-
May 6, 2026, 14:02Abdul Mannan: Anemia in Myelofybrosis – Five Fires Behind One Falling Hb
-
May 6, 2026, 14:00Mona Alfaraj: Advancing Care in Inherited Platelet Disorders at 2nd International Hematology and Hemostasis Conference
-
May 6, 2026, 13:56Mahesan Subramaniam: Why Delayed Cord Clamping Benefits Newborn Health
-
May 6, 2026, 13:44Wolfgang Miesbach: Octreotide as a First‑Line Systemic Option in VWD Patients With Angiodysplasia‑Related GI Bleeding
-
May 6, 2026, 13:42Irogue Igbinosa: Rethinking Iron Deficiency in Pregnancy with Intravenous Therapy
-
May 6, 2026, 13:34Manaf Aljishi: Three Posters Presented at the Hematology and Hemostasis Conference 2026
-
May 6, 2026, 13:33David Ferreira: Insights from the 1st National Meeting of Young Immunohematologists in Abrantes
-
May 6, 2026, 13:22Nicholas Lee: Honored to Join ASH CRTI Program for Aplastic Anemia Research